DRREDDY had a remarkable week, posting a 5.8% return, significantly outperforming its peers. The stock's volatility was high at 37.86%, indicating a risky investment environment. Despite the high volatility, the stock's Sharpe Ratio of 0.60 suggests that the returns were somewhat justified by the risk taken. In comparison, peers such as DIVISLAB, SUNPHARMA, and HINDUNILVR all posted negative returns, making DRREDDY a standout performer this week.

[Volatility: 37.86%]